News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
135 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17865)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (228)
2 (201)
3 (256)
4 (88)
6 (3)
7 (176)
8 (256)
9 (209)
10 (241)
11 (82)
12 (1)
13 (1)
14 (211)
15 (144)
16 (102)
17 (110)
18 (49)
20 (2)
21 (105)
22 (152)
23 (135)
24 (137)
25 (50)
26 (2)
27 (5)
28 (142)
29 (180)
30 (175)
31 (146)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
20
21
22
23
24
25
26
27
28
29
30
31
Business
MDxHealth Reports Q2 and Half Year 2023 Results
MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the second quarter and half year ended June 30, 2023.
August 23, 2023
·
11 min read
BioForest
Gilead Sciences to Present at Upcoming September 2023 Investor Conferences
Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conferences.
August 23, 2023
·
1 min read
Drug Development
Centessa Pharmaceuticals to Present Preclinical Data for Novel Orexin Receptor 2 (OX2R) Agonist at World Sleep Congress
Centessa Pharmaceuticals plc announced that preclinical data for ORX750, its first orexin agonist development candidate, will be featured in an oral presentation at the World Sleep Congress being held on October 20-25, 2023, in Rio de Janeiro, Brazil.
August 23, 2023
·
5 min read
Business
Evolus Announces Inducement Grants for New Chief Marketing Officer
Evolus, Inc. announced that the Compensation Committee of the Board of Directors approved the grant of stock options to purchase an aggregate of 83,555 shares of Evolus common stock and 63,358 restricted stock units to Tomoko Yamagishi-Dressler, the company’s new Chief Marketing Officer.
August 23, 2023
·
2 min read
Business
Akebia Therapeutics to Report Second Quarter Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the second quarter ended June 30, 2023 on Friday, August 25, 2023.
August 23, 2023
·
1 min read
Pharm Country
Regeneron Announces Investor Conference Presentations - August 23, 2023
Regeneron Pharmaceuticals, Inc. will webcast management participation.
August 23, 2023
·
1 min read
Pharm Country
RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference
RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced that Brian Markison, Chief Executive Officer, will participate in a fireside chat and host 1x1 investor meetings at the H.C. Wainwright 25th Annual Global Investment Conference in New York City.
August 23, 2023
·
2 min read
Business
Mirati Therapeutics Announces Departure of Chief Financial Officer Laurie Stelzer
Mirati Therapeutics, Inc.®, a commercial stage biotechnology company, announced that Laurie Stelzer, Chief Financial Officer, will depart the company on September 8, 2023, to pursue an external opportunity.
August 23, 2023
·
3 min read
Biotech Bay
Penumbra, Inc. to Present at Upcoming September 2023 Investor Conferences
Penumbra, Inc. announced that its management team is scheduled to present at the following investor conferences.
August 23, 2023
·
1 min read
BioCapital
REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023
REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023 in Jerusalem, Israel (August 29 – September 1).
August 23, 2023
·
2 min read
Previous
12 of 14
Next